Feed NVS
NV

Novartis NVS · NYSE

$161.47 +0.23% (+$0.37)

Market cap
$304.2B
Enterprise value
$345.6B
P/E
23.8x
Forward P/E
17.8x
PEG
1.2x
P/S
5.5x
P/FCF
19.2x
EV/EBITDA
15.5x
ROIC
13.9%
Bruto marža
74.4%
Neto marža
22.9%
Dividend yield
2.94%
Payout ratio
70.2%
Neto dolg/EBITDA
1.9x
Beta
0.42
Free float
96.9%

O podjetju

Novartis AG is a Swiss global pharmaceutical company with a broad portfolio of medicines and healthcare products. The company is one of the leading players in the pharmaceutical industry and operates worldwide. Novartis focuses on the development, manufacturing, and distribution of innovative medicines in various therapeutic areas, including oncology, cardiology, ophthalmology, neurology, and others. The company also specializes in the production and sale of generic drugs. Novartis dedicates significant efforts to research and development of new treatment options to help improve the quality of life for patients around the world. The company actively collaborates with medical professionals and institutions to ensure the best care for patients. Novartis AG (NVS) shares are an attractive choice for investors who follow the pharmaceutical industry and seek investment opportunities in a reputable company with a rich medical portfolio and a long history of innovation.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Vasant Narasimhan

Employees

75,267

Headquarters

Basel

Vrednotenje

Je današnja cena primerna?

  • Kaj govori v prid: Cena delnice je pod Bulios Fair Price.

Rast in ocene

Ali podjetje raste in kaj sledi?

  • Kaj govori v prid: Dobiček na delnico je v zadnjih 3 letih rasel za 31 % letno.
  • Na kaj bodite pozorni: Dobiček na delnico iz leta v leto močno niha.

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

  • Kaj govori v prid: Od vsakih 100 USD prihodkov ostane 23 USD čistega dobička.
  • Kaj govori v prid: Na vsakih 100 USD vloženega kapitala zasluži 14 USD letno.

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe.